Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.

[1]  Marcel van Herk,et al.  Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  R. T. Ten Haken,et al.  High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. , 2005, International journal of radiation oncology, biology, physics.

[3]  Sadek Nehmeh,et al.  Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? , 2005, International journal of radiation oncology, biology, physics.

[4]  Ludy Lutgens,et al.  Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. , 2005, International journal of radiation oncology, biology, physics.

[5]  Suresh Senan,et al.  Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[6]  C. Ling,et al.  Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[7]  D. Ettinger,et al.  Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.

[8]  Sasa Mutic,et al.  Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[9]  J. Vansteenkiste,et al.  Positron emission tomography in the management of non-small cell lung cancer. , 2004, Hematology/oncology clinics of North America.

[10]  Joos V Lebesque,et al.  Biologic and physical fractionation effects of random geometric errors. , 2003, International journal of radiation oncology, biology, physics.

[11]  Cyrill Burger,et al.  Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.

[12]  Tsuneo Suzuki,et al.  Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. , 2003, Chest.

[13]  Curtis B Caldwell,et al.  Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. , 2003, International journal of radiation oncology, biology, physics.

[14]  Shogo Yamada,et al.  A novel support system for patient immobilization and transportation for daily computed tomographic localization of target prior to radiation therapy. , 2003, International journal of radiation oncology, biology, physics.

[15]  L. Boersma,et al.  First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  U. Nestle,et al.  [Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET]. , 2002, Nuklearmedizin. Nuclear medicine.

[17]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[18]  R. Fisher,et al.  Measurement of lung tumor volumes using three-dimensional computer planning software. , 2002, International journal of radiation oncology, biology, physics.

[19]  J. V. van Meerbeeck,et al.  Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  C. Rübe,et al.  2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[21]  Joos V Lebesque,et al.  Inclusion of geometric uncertainties in treatment plan evaluation. , 2002, International journal of radiation oncology, biology, physics.

[22]  Kurt Baier,et al.  Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.

[23]  Curtis B Caldwell,et al.  The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. , 2002, International journal of radiation oncology, biology, physics.

[24]  Jan Pruim,et al.  Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11 tyrosine and positron emission tomography , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  K. Mah,et al.  Clinical investigation: lungObserver variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion☆ , 2001 .

[26]  Marcel van Herk,et al.  Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  K. Langen,et al.  Organ motion and its management. , 2001, International journal of radiation oncology, biology, physics.

[28]  J C Rosenwald,et al.  CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. , 2001, International journal of radiation oncology, biology, physics.

[29]  B. Heijmen,et al.  Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based external beam radiotherapy dose planning. , 2001, International journal of radiation oncology, biology, physics.

[30]  J. Bonner,et al.  Unresectable or medically inoperable non-small cell lung cancer: the use of established clinical prognostic factors in making radiation-related treatment decisions. , 2000, Seminars in radiation oncology.

[31]  Gerald J. Kutcher,et al.  The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer , 2000 .

[32]  A. Al-Amro,et al.  F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection. , 2000, Clinical nuclear medicine.

[33]  S Senan,et al.  Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  M. Shakudo,et al.  Thallium and FDG uptake by atelectasis with bronchogenic carcinoma , 1999, Annals of nuclear medicine.

[35]  K Schnabel,et al.  18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.

[36]  S Senan,et al.  An analysis of anatomic landmark mobility and setup deviations in radiotherapy for lung cancer. , 1999, International journal of radiation oncology, biology, physics.

[37]  R. Coleman,et al.  Evaluation of patients with round atelectasis using 2-[18F]-fluoro-2-deoxy-D-glucose PET. , 1998, Journal of computer assisted tomography.

[38]  G. Sibley.  Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma , 1998, Cancer.

[39]  M van Herk,et al.  The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. , 1997, International journal of radiation oncology, biology, physics.

[40]  C. Mountain,et al.  Regional lymph node classification for lung cancer staging. , 1997, Chest.

[41]  S. Davies,et al.  Big brother : Britain's web of surveillance and the new technological order , 1996 .

[42]  H. Kooy,et al.  Automatic three-dimensional correlation of CT-CT, CT-MRI, and CT-SPECT using chamfer matching. , 1994, Medical physics.

[43]  Marcel van Herk,et al.  Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[44]  G. V. von Schulthess,et al.  Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  Jeffrey D Bradley,et al.  Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[46]  Arjan Bel,et al.  Definition of gross tumor volume in lung cancer: inter-observer variability. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  Bernard Dubray,et al.  Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  John L. Humm,et al.  Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[49]  S. Senan,et al.  2158 An analysis of anatomic landmark mobility and setup errors in radiotherapy for lung cancer , 1997 .

[50]  James A. Purdy,et al.  3-D Conformal Radiotherapy for Lung Cancer , 1996 .